RTV-22081-53339
3 vaccinations
6 coded responses
28 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
- 2021-01-07
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-22
-
2021-01-26
Dose 2 — Pfizer-BioNTech
- 2021-01-27
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Neck pain, Swelling — Feeling: PoorFree text: Very swollen and sore left trap to left side of neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Moderate Supraclavicular lymphadenopathy (left side)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Mild Supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Mild resolving Supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-16
- 2021-02-24
- 2021-03-02
- 2021-03-09
- 2021-05-01
- 2021-07-27
-
2021-10-19
Dose 3 — Pfizer-BioNTech
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Supraclavicular lymphadenopathy on side of injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-22
- 2021-10-23
- 2021-10-26
- 2021-11-04
- 2021-11-11
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2022-01-18
-
2022-04-19
Survey response — 6 months, dose 3MedDRA: Cough, Nasal congestion, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Residual post-COVID nasal congestion and lingering coughMedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Very swollen and sore left trap to left side of neck
Systemic reaction (other): Moderate Supraclavicular lymphadenopathy (left side)
Systemic reaction (other): Mild Supraclavicular lymphadenopathy
Systemic reaction (other): Mild resolving Supraclavicular lymphadenopathy
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Supraclavicular lymphadenopathy on side of injection site
Release 11 — 6 months, dose 3
Symptoms: Residual post-COVID nasal congestion and lingering cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Neck pain | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release